Cornerstone Wealth Group LLC Buys 801 Shares of The Clorox Company (NYSE:CLX)

Cornerstone Wealth Group LLC boosted its stake in The Clorox Company (NYSE:CLX) by 3.9% during the 4th quarter, HoldingsChannel reports. The fund owned 21,497 shares of the company’s stock after acquiring an additional 801 shares during the quarter. Cornerstone Wealth Group LLC’s holdings in Clorox were worth $3,491,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. State Street Corp lifted its position in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC raised its position in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC increased its position in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after buying an additional 33,970 shares during the last quarter. Stifel Financial Corp raised its stake in Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Van ECK Associates Corp raised its holdings in Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after acquiring an additional 31,510 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Price Performance

Shares of CLX opened at $159.12 on Monday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The stock has a market cap of $19.70 billion, a PE ratio of 55.44, a PEG ratio of 2.92 and a beta of 0.42. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The business has a 50-day simple moving average of $163.66 and a two-hundred day simple moving average of $157.50.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The firm’s revenue was up 27.0% compared to the same quarter last year. Analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.07%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. boosted their price target on Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. Evercore ISI reduced their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. Finally, Barclays decreased their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating on the stock in a research note on Friday, January 17th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $156.54.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.